Hosted by the American Thoracic Society, the 2022 Respiratory Innovation Summit will unite the innovators, investors, clinicians and advocacy groups who are leading the charge to create powerful new treatments for deadly and crippling diseases of the lungs and airways. This meeting historically attracts 200+ global leaders representing all facets of the respiratory industry, including representatives from start-ups, business development, venture capital, government, academia and clinical medicine.

For 2022, the focus areas are fibrosis, inflammation, and COVID-19. Each area will feature an expert panel discussion and five innovating companies in focused, interactive burst sessions. The agenda also includes a CEO panel, business development panel, and plenty of time for networking among posters from innovative companies.

Registration Link